Characteristics of IL-17 Induction by Schistosoma Japonicum Infection in C57BL/6 Mouse Liver
Overview
Affiliations
Schistosomiasis japonica is a severe tropical disease caused by the parasitic worm Schistosoma japonicum. Among the most serious pathological effects of S. japonicum infection are hepatic lesions (cirrhosis and fibrosis) and portal hypertension. Interleukin-17 (IL-17) is a pro-inflammatory cytokine involved in the pathogenesis of many inflammatory and infectious conditions, including schistosomiasis. We infected C57BL/6 mice with S. japonicum and isolated lymphocytes from the liver to identify cell subsets with high IL-17 expression and release using flow cytometry and ELISA. Expression and release of IL-17 was significantly higher in hepatic lymphocytes from infected mice compared with control mice in response to both non-specific stimulation with anti-CD3 monoclonal antibody plus/anti-CD28 monoclonal antibody and PMA plus ionomycin. We then compared IL-17 expression in three hepatic T-cell subsets, T helper, natural killer T and γδT cells, to determine the major source of IL-17 during infection. Interleukin-17 was induced in all three subsets by PMA + ionomycin, but γδT lymphocytes exhibited the largest increase in expression. We then established a mouse model to further investigate the role of IL-17 in granulomatous and fibrosing inflammation against parasite eggs. Reducing IL-17 activity using anti-IL-17A antibodies decreased infiltration of inflammatory cells and collagen deposition in the livers of infected C57BL/6 mice. The serum levels of soluble egg antigen (IL)-specific IgGs were enhanced by anti-IL-17A monoclonal antibody blockade, suggesting that IL-17 normally serves to suppress this humoral response. These findings suggest that γδT cells are the most IL-17-producing cells and that IL-17 contributes to granulomatous inflammatory and fibrosing reactions in S. japonicum-infected C57BL/6 mouse liver.
Mertelsmann A, Bowers S, Wright D, Maganga J, Mazigo H, Ndhlovu L PLoS Negl Trop Dis. 2024; 18(9):e0012456.
PMID: 39250522 PMC: 11412685. DOI: 10.1371/journal.pntd.0012456.
Evaluation of the TLR3 involvement during Schistosoma japonicum-induced pathology.
Xie H, Chen D, Feng Y, Mo F, Liu L, Xing J BMC Immunol. 2024; 25(1):2.
PMID: 38172683 PMC: 10765740. DOI: 10.1186/s12865-023-00586-9.
The IL-17 family in diseases: from bench to bedside.
Huangfu L, Li R, Huang Y, Wang S Signal Transduct Target Ther. 2023; 8(1):402.
PMID: 37816755 PMC: 10564932. DOI: 10.1038/s41392-023-01620-3.
Wan J, Zhang Q, Hao Y, Tao Z, Song W, Chen S Front Cell Infect Microbiol. 2023; 13:1149506.
PMID: 37475963 PMC: 10354519. DOI: 10.3389/fcimb.2023.1149506.
Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis.
Liu Z, Zhang L, Liang Y, Lu L Front Cell Infect Microbiol. 2022; 12:1035765.
PMID: 36389166 PMC: 9650140. DOI: 10.3389/fcimb.2022.1035765.